Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model

about

Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model

Item

http://www.wikidata.org/entity/Q56395905

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Immunogenicity and Protection ...... r Vaccine in the Hamster Model

@en

Immunogenicity and Protection ...... r Vaccine in the Hamster Model

@nl

type

Item

label

Immunogenicity and Protection ...... r Vaccine in the Hamster Model

@en

Immunogenicity and Protection ...... r Vaccine in the Hamster Model

@nl

prefLabel

Immunogenicity and Protection ...... r Vaccine in the Hamster Model

@en

Immunogenicity and Protection ...... r Vaccine in the Hamster Model

@nl

P1476

Immunogenicity and Protection ...... r Vaccine in the Hamster Model

@en

P2093

Ariane Volkmann

http://www.w3.org/2001/XMLSchema#string

Cédric Cheminay

http://www.w3.org/2001/XMLSchema#string

Justin G Julander

http://www.w3.org/2001/XMLSchema#string

Marco Testori

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model

Yellow Fever — Once Again on the Radar Screen in the Americas

Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.

Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States

Potential risk of re-emergence of urban transmission of Yellow Fever virus in Brazil facilitated by competent Aedes populations.

Adverse event reports following yellow fever vaccination.

BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model

Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease.

Yellow fever: the recurring plague.

Yellow fever.

P304

1756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.01756

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30116244

http://www.w3.org/2001/XMLSchema#string

P921

yellow fever virus

P932

6082969

http://www.w3.org/2001/XMLSchema#string